SK Biopharm to Promote Open Innovation with Global Venture Capital
[Asia Economy Reporter Cho Hyun-ui] SK Biopharm announced on the 2nd that it will promote open innovation in collaboration with the global healthcare venture capital company 'LifeSci'.
LifeSci is a global healthcare venture capital firm focused on investing in next-generation bio companies. It is the venture investment arm of 'LifeSci Partners,' a life sciences and healthcare consulting company established in 2010.
SK Biopharm expects to leverage LifeSci's network and expertise to proactively invest in early-stage new drug candidates and technologies, as well as to build strategic relationships with promising US bio-venture companies.
Hot Picks Today
!["Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051609052165501_1778889921.jpg)
"Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]
- Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- AI Said to Eliminate Jobs, but This Role Sees 800% Surge in Hiring [Tech Talk]
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
Yoo Chang-ho, Head of Management Strategy at SK Biopharm, stated, "As a strategic investor in the fund, SK Biopharm plans to expand partnerships with promising ventures to strengthen global competitiveness."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
